Measles-containing-vaccine second-dose (MCV2) immunization coverage in Bahamas
Bahamas: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 65.0% in 2025. ▲ Rising
Latest (2025)
65.0%
Change on year
up 8.3%
World rank
153rd
of 194 countries
All-time high
95.0%
in 2004
All-time low
0.0%
in 2000
Years of data
26
2000–2025
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Bahamas, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, measles-containing-vaccine second-dose (mcv2) immunization coverage in Bahamas stood at 65.0%.
That represents a change of up 8.3% on the previous year and down 14.5% over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Bahamas peaked at 95.0% in 2004 and was at its lowest, 0.0%, in 2000.
Bahamas ranks 153rd of 194 countries on this measure, in the bottom quarter.
The long-run direction has been consistently rising across the 26 years of available data.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Bahamas, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 95.0% | — |
| 2005 | 88.0% | -7.4% |
| 2006 | 88.0% | +0.0% |
| 2007 | 84.0% | -4.5% |
| 2008 | 80.0% | -4.8% |
| 2009 | 76.0% | -5.0% |
| 2010 | 78.0% | +2.6% |
| 2011 | 79.0% | +1.3% |
| 2012 | 73.0% | -7.6% |
| 2013 | 69.0% | -5.5% |
| 2014 | 72.0% | +4.3% |
| 2015 | 76.0% | +5.6% |
| 2016 | 74.0% | -2.6% |
| 2017 | 76.0% | +2.7% |
| 2018 | 69.0% | -9.2% |
| 2019 | 83.0% | +20.3% |
| 2020 | 83.0% | +0.0% |
| 2021 | 80.0% | -3.6% |
| 2022 | 65.0% | -18.8% |
| 2023 | 53.0% | -18.5% |
| 2024 | 60.0% | +13.2% |
| 2025 | 65.0% | +8.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 51.1% | 0.0% | 95.0% | 10 |
| 2010s | 74.9% | 69.0% | 83.0% | 10 |
| 2020s | 67.7% | 53.0% | 83.0% | 6 |
Countries ranked near Bahamas
- 153 Burkina Faso 65.0% compare
- 155 Congo 63.0% compare
- 156 Syrian Arab Republic 62.0% compare
- 156 Kazakhstan 62.0% compare
More health data for Bahamas
- Un projection of annual infant deaths, annual growth rate -11.11 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.0809 % change on previous year (2090)
- Heat deaths vs projected death rates 1,358 (2090)
- Un projection of annual infant deaths 8 (2100)
- Population ages 15-64, male, annual growth rate 0.5299 % change on previous year (2025)
- Population ages 15-64, male, per unit of GDP 0 units per US$ of GDP (2024)
- Population ages 15-64, male, per capita 0.3375 units per person (2025)
- Population ages 15-64, total, annual growth rate 0.5012 % change on previous year (2025)
- Population ages 15-64, total, per unit of GDP 0 units per US$ of GDP (2024)
- Population ages 15-64, total, per capita 0.7036 units per person (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Bahamas?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Bahamas was 65.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Bahamas?
- The highest recorded value was 95.0% in 2004.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Bahamas?
- The lowest recorded value was 0.0% in 2000.
- How does Bahamas rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Bahamas ranks 153rd out of 194 countries with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Bahamas?
- Over the last ten years it is down 14.5%. The long-run trend across the full record is rising.
- Where does this Bahamas data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).